Stavudine or stavidine
- Level
- Commodity
- Parent
- 51343000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343004This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BO9LE4QFZF. European Medicines Agency schedules Stavudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10642MIG. Stavudine generally arises in the molecular formula C10H12N2O4. The term STAVUDINE is an International Non-Proprietary Name or INN. STAVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Stavudine or stavidine bears US NLM identifiers UMLS ID C0164662 and NCI Concept Code C1428. SMILES: CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO.
Same parent
Under 51343000 · 8Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.